The extensively studied effects of digitalis drugs (cardiac glycosides) on the heart, and the uses of these drugs in the therapy of congestive heart failure and other cardiac disorders, are presented in standard textbooks. Less well known are the periodic reports that have suggested the potential value of these drugs in the treatment of various cancers (Haux, 1999; Repke et al., 1995; Stenkvist, 1999; and references therein) . While most of this research has been done on cancer cells in vitro, of particular interest are the studies that have suggested the beneficial effects of digitalis treatment in women with breast cancer (Stenkvist, 1999; Stenkvist et al., 1979 Stenkvist et al., ,1980 Stenkvist et al., ,1982 . These studies were the prime stimulus for the work presented here.
Digitalis effect on cardiac contractility (the positive inotropic effect) is known to be due to the drug's highly specific interaction with Na + /K + -ATPase; the enzyme that maintains the normal gradients of Na + and K + across the plasma membrane of most eukaryotic cells (Skou and Esmann, 1992) . Decades ago it was established that partial inhibition of the ion pumping function of cardiac Na + /K + -ATPase by digitalis leads to a modest increase in intracellular Na + , which in turn affects the cardiac sarcolemmal Na + /Ca 2+ exchanger, causing a significant increase in intracellular Ca 2+ and in the force contraction (Akera and Brody, 1978; Schwartz et al., 1975; Smith, 1988) . This positive inotropic action of digitalis is generally assumed to be a basis of its utility in the treatment of congestive heart failure (Kjelden et al., 2002; Smith, 1988) . More recently, it has been shown that the fraction of the cardiac myocyte Na + /K + -ATPase whose ion pumping function has been inhibited by digitalis participates in protein-protein interactions that lead to activation of multiple growth-related signal transduction pathways, and that some of these activated pathways are also essential to digitalis-induced increase in contractility (Mohammadi et al., 2003; Tian et al., 2001; Xie and Askari, 2002) . Thus, both the ion pumping function and the Because of the suggested value of digitalis in the treatment of human breast cancer, and due to the paucity of mechanistic studies on digitalis interaction with breast cancer cells, it seemed worthwhile to begin a systematic study of digitalis effects on the ion pumping and the signal transducing functions of Na This article has not been copyedited and formatted. The final version may differ from this version. ATPase of the intact cells was assayed by the procedures we described before (Kometiani et al., 2001) . Uptake that was inhibited by 10 µM or higher concentrations of ouabain was taken as the maximal rate of active uptake.
Intracellular Na + Content. Estimation of relative change in intracellular Na + was done according to Kim et al. (1984) . Briefly, cells were incubated at 37°C in the culture medium containing trace amounts of 22 Na + for 45 min to fully equilibrate exchangeable intracellular Na + with 22 Na + . The indicated concentrations of ouabain were then added, and incubations were continued for 30 min. Control and ouabain-treated cells were then washed in ice-cold solution of 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 50 mM Tris-HCl (pH 7.4). After homogenization and centrifugation at 16,000 x g for 10 min, the supernatant was assayed for Src kinase activity as we described before (Mohammadi et al., 2003) . The same supernatant was also used for the assay of total ERK1/2 and phospho-ERK1/2 by immunoblot analysis as we reported before (Kometiani et al., 1998; Mohammadi et al., 2003) . Similarly, to detect activation of JNK and p38 kinase, ratios of phosphorylated/activated kinases to total kinases were determined by Western analysis of the supernatants of the cell lysates.
Immunoblot Analysis and Co-immunoprecipitation. Supernatants of cell lysates, as prepared above, were subjected to SDS-PAGE, transferred to nitrocellulose membranes, and probed with appropriate antibodies by standard procedures. The immunoreactive bands were detected using chemiluminescence. For quantitative comparisons, images were scanned with a densitometer. Different dilutions of samples were subjected to SDS-PAGE, and multiple exposures of films were used to ensure that quantitations were made within the linear range of the assays. The results were expressed in arbitrary units per unit of lysate protein.
Co-immunoprecipitation experiments were done on the supernatant of the cell lysates, using an anti-EGFR antibody and protein G-Agarose beads, by standard procedures (Haas et al., 2000) . Precipitated proteins were removed from the beads by SDS sample buffer, and subjected to Western analysis using appropriate antibodies against the indicated proteins.
Protein was determined by the Bio-Rad DC protein colorimetric assay (Bio-Rad,
Hercules, CA).
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RESULTS
The human breast cancer cell line MDA-MB-435s was used in all of the studies presented below. This estrogen receptor-negative cell line was chosen to avoid the possibility of digitalis interaction with estrogen receptor. Ouabain was used in most of the experiments because the great majority of the previous in vitro studies on cardiac glycosides have been done with this prototype drug. Selected experiments were also repeated with digoxin and digitoxin, the two digitalis drugs that are most widely used for therapeutic purposes.
Ouabain Sensitivity of the Ion Pumping Function of Na It is well established that because of the "reserve capacity" of Na
cell with normal gradients of Na + and K + across its membrane, the partial inhibition of the enzyme does not necessarily lead to significant changes in intracellular Na + and K + concentrations (Akera and Brody, 1978; Akera and Ng, 1991; Kim et al., 1984; Liu et al., 2000) .
Experiments of Fig This article has not been copyedited and formatted. The final version may differ from this version. (Haas et al., 2000 (Haas et al., ,2002 Kometiani et al., 1998) are also activated in breast cancer cells at ouabain concentrations that arrest the growth of these cells. Because the duration and the level of ERK1/2 activation is often related to the nature of the growth-related response elicitated by a signal (Marshall, 1995; Woods et al., 1997) , effect of 100 nM ouabain on ERK1/2 was also examined up to 12 h after exposure. A sustained phase of activation that followed the initial rapid and transient phase was clearly evident (Fig. 6c ).
Ouabain Effects on p21 Cip1 , p53, JNK, and p38 Kinase -To begin the assessment of the mechanism of the ouabain-induced growth arrest in MDA-MB-435s cells, we examined the drug's effects on a number of established regulators of cell cycle and proliferation. Ouabain had a dose-and time-dependent stimulatory effect on the expression of p21 Cip1 (Fig. 7) , and an inhibitory effect on the expression of p53 (Fig. 8) . Ouabain (100 nM) exhibited a timedependent activating effect on JNK (Fig. 9 ), but had no effect on p38 kinase activity (not shown).
Digoxin and Digitoxin Effects -To compare the effects of ouabain with those of the two therapeutically used digitalis drugs, the following limited experiments were done. At
This article has not been copyedited and formatted. The final version may differ from this version. concentrations lower than 100 nM, both digitoxin and digoxin caused activation of ERK1/2 ( Fig.   10 ) and inhibition of proliferation (Fig. 11) , though digitoxin seemed to be more effective than digoxin. This apparent superiority of digitoxin over digoxin has also been noted in experiments of others on the growth inhibitory effects of the two drugs on breast cancer cell lines other than the one used here (Haux et al., 1999a; Kimijima et al., 1992) .
DISCUSSION
The epidemiological studies of Stenkvist et al. (1979 Stenkvist et al. ( ,1980 Stenkvist et al. ( ,1982 suggested that tumors of the breast cancer patients treated with digitalis drugs exhibited more benign characteristics, and had reduced recurrence rates, than those of the patients not treated with digitalis. Prompted by these observations, others have reported growth inhibitory effects of these drugs, at concentrations at or near therapeutic blood levels, on human breast cancer cells in culture (Falconer et al., 1983; Haux et al., 1999a Haux et al., ,1999b Kimijima et al., 1992) . We have now confirmed and extended these observations to explore molecular mechanisms for the growth inhibitory effects of digitalis drugs on breast cancer cells.
Concerning the growth inhibitory effects of digitalis drugs, it is important to note that when used at sufficiently high concentrations that alter the normal Na Ouabain-induced upregulation of p21 Cip1 (Fig. 7) , an established cell cycle inhibitor (McMahon and Woods, 2001 ) is the likely explanation of the antiproliferative effect of the drug.
The significance of the concomitant downregulation of p53 ( . We find that ouabain activates JNK, but not p38 kinase ( Fig. 9 and Results). The pathways of ouabain-induced activation of JNK, and possible interactions of ERK1/2 and JNK pathways in the regulation of the growth of these cells also remain to be explored.
This article has not been copyedited and formatted. The final version may differ from this version. An important question is whether or not digoxin and digitoxin effects on breast cancer in vivo may be expected if patients are treated with the established dosage regimens that have been used for patients in congestive heart failure. Using such regimens, the therapeutic plasma levels of digoxin and digitoxin are considered to be in the ranges of 0.6-1.9 nM and 13-33 nM respectively (Katzung and Parmley, 2000) . Based on our data (Fig. 11) , and those of others who have noted growth inhibitory effects of digoxin and digitoxin on several breast cancer cell lines other than MDA-MB-435s cells (Haux et al., 1999a; Kimijima et al., 1992) , we conclude that in vitro the upper therapeutic levels of digoxin are at the threshold of being inhibitory, but that therapeutic digitoxin concentrations cause significant inhibitory effects. Taking the liberty of extrapolating from in vitro to in vivo conditions, and considering the long-standing observations on digitalized breast cancer patients, we suggest that the previous pleas for further studies on the potential use of digitalis in the therapy of cancer (Haux, 1999; Stenkvist, 1999) were well justified, at least in the case of breast cancer. It is regrettable that the neglect of this potential of digitalis has been a side effect of the constant and legitimate search for new drugs.
This article has not been copyedited and formatted. The final version may differ from this version. Effects of varying concentrations of ouabain on intracellular Na + content. After equilibration of intracellular Na + with 22 Na + (Materials and Methods), the indicated concentrations of ouabain were added to the culture medium, and changes in intracellular 22 Na + relative to that of untreated control were determined. n=6; *p<0.05 compared to control. Ouabain-induced activation of JNK. Cells were exposed to 100 nM ouabain for the indicated durations, lysates were subjected to immunoblot analysis of the phosphorylated and total JNK proteins, and the results were quantitated as indicated in legend to Fig. 6 . n=3; *p<0.05. Fig. 10 . Activation of ERK1/2 by digoxin and digitoxin. Cells were exposed to the indicated drug concentrations for 5 min, and the assays were done as described in legend to Fig. 6. n=6; *p<0.05. 
